최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Scandinavian journal of infectious diseases, v.33 no.2, 2001년, pp.101 - 105
Boshoff, Helena I. M. , Durbach, Steven I. , Mizrahi, Valerie
In this paper, we review the evidence supporting the notion that the genome of Mycobacterium tuberculosis sustains considerable damage as a result of exposure to nitrosative and oxidative stress. On these grounds, we propose a model in which stress-induced DNA damage in M. tuberculosis plays a role in the evolution of chromosomally encoded drug resistance mutations by altering the global mutation rate by mechanisms akin to SOS mutagenesis. Finally we review some of the factors determining the evolution of PE/PPE and MIRU (There are many abbreviations in this paper which are not defined, e.g. SOS, PE/PPE and MIRU. Please indicate whether these are well known and will be understood by readers or whether they should be defined at first mention) loci whose sequence characteristics are suggestive of their classification as heritable local mutators.
Tuber Lung Dis Ramaswamy S 3 79 1998 10.1054/tuld.1998.0002
Proc Natl Acad Sci USA Sreevatsan S 9869 94 1997 10.1073/pnas.94.18.9869
Negligible genetic diversity of Mycobacterium tuberculosis host immune system protein targets. Evidence of limited selective pressure. Genetics Musser JM 7 155 2000
Am Rev Respir Dis David HL 508 104 1971
Cell Metzgar D 581 101 2000 10.1016/S0092-8674(00)80869-7
What have we learnt from the genome sequence? Mol Microbiol Mizrahi V 1331 29 1998
J Bacteriol Nyka W 1458 93 1967 10.1128/JB.93.4.1458-1460.1967
Infect Immun Nyka W 843 9 1974 10.1128/IAI.9.5.843-850.1974
Tuber Lung Dis Wayne LG 127 79 1998 10.1054/tuld.1998.0015
Anaerobic nitrate reductase (narGHJI) activity of Mycobacterium bovis BCG in vitro and its contribution to virulence in immunodeficient mice. Mol Microbiol Weber I 1017 35 2000
Ferrous iron dependent nitric oxide production in nitrate reducing cultures of Escherichia coli. Arch Microbiol Brons HJ 341 155 1991
Response of Mycobacterium tuberculosis to reactive oxygen and nitrogen intermediates. Mol Med Garbe TR 134 2 1996
Response to reactive nitrogen intermediates in Mycobacterium tuberculosis: induction of the 16-kilodalton alpha-crystallin homolog by exposure to nitric oxide donors. Infect Immun Garbe TR 460 67 1999
J Exp Med Ehrt S 1885 186 1998 10.1084/jem.186.11.1885
Coates AR. Regulation of hmp gene transcription in Mycobacterium tuberculosis: effects of oxygen limitation and nitrosative and oxidative stress. J Bacteriol Hu Y 3486 181 1999
Infect Immun Ruan J 3276 67 1999 10.1128/IAI.67.7.3276-3283.1999
Infect Immun Wayne LG 2062 64 1996 10.1128/IAI.64.6.2062-2069.1996
Protein synthesis is shut down in dormant Mycobacterium tuberculosis and is reversed by oxygen or heat shock. FEMS Microbiol Lett Hu YM 139 158 1998
Novartis Found Symp Foster JW 55 221 1999
J Bacteriol Taverna P 5105 178 1996 10.1128/jb.178.17.5105-5111.1996
Proc Natl Acad Sci USA Sherman DR 6625 92 1995 10.1073/pnas.92.14.6625
Mol Microbiol Deretic V 889 17 1995 10.1111/j.1365-2958.1995.mmi_17050889.x
Loss of oxy R in Mycobacterium tuberculosis. Trends Microbiol Deretic V 367 5 1997
Trends Microbiol Dussurget O 354 6 1998 10.1016/S0966-842X(98)01307-9
Identification and functional characterization of thioredoxin of Mycobacterium tuberculosis. Infect Immun Wieles B 4946 63 1995
Infect Immun Weldingh K 3492 66 1998 10.1128/IAI.66.8.3492-3500.1998
A model for studying export of leaderless proteins by pathogenic mycobacteria. J Biol Chem Harth G 4281 274 1999
Wayne, L. G.. Dormancy ofMycobacterium tuberculosis and latency of disease. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, vol.13, no.11, 908-914.
Trends Microbiol CE III Barry 275 4 1996 10.1016/0966-842X(96)10031-7
Mycobacterium tuberculosis catalase and peroxidase activities and resistance to oxidative killing in human monocytes in vitro. Infect Immun Manca C 74 67 1999
The Mycobacterium tuberculosis katG promoter region contains a novel upstream activator. Microbiology Mulder MA 2507 145 1999
Mut Res Bridges BA 1 408 1998 10.1016/S0921-8777(98)00008-1
Nature Cox MM 37 404 2000 10.1038/35003501
Nature Radman M 866 401 1999 10.1038/44738
Proc Natl Acad Sci USA Gerlach VL 11922 96 1999 10.1073/pnas.96.21.11922
Molecular genetics of mycobacteria Colston MJ 85 2000
Proc Natl Acad Sci USA Graham JE 11554 96 1999 10.1073/pnas.96.20.11554
Trends Microbiol Clements MO 458 7 1999 10.1016/S0966-842X(99)01607-8
Cell Friedberg E 413 98 1999 10.1016/S0092-8674(00)81970-4
Proc Natl Acad Sci USA Johnson RE 12224 96 1999 10.1073/pnas.96.22.12224
J Bacteriol Wagner J 4587 182 2000 10.1128/JB.182.16.4587-4595.2000
J Bacteriol Karunakaran P 3331 182 2000 10.1128/JB.182.12.3331-3335.2000
Ciba Found Symp Lipsitch M 112 207 1997
Int J Tuberc Lung Dis Lipsitch M 187 2 1998
Int J Tuberc Lung Dis Mitchison DA 10 2 1998
Biochem Pharmacol CE III Barry 221 59 2000 10.1016/S0006-2952(99)00253-1
Granuloma-specific expression of Mycobacterium virulence proteins from the glycine-rich PE-PGRS family. Science Ramakrishnan L 1436 288 2000
Am Rev Tuberc McDermott W 748 70 1954
Zhang Y. pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, Canada. Antimicrob Agents Chemother Cheng SJ 528 44 2000
Brosch R, Gordon SV, Eiglmeier K, Garnier T, Tekaia F, Yeramian E, et al. Genomics, biology and evolution of the Mycobacterium tuberculosis complex. In: Hatfull GF, Jacobs WR Jr., eds. Molecular genetics of mycobacteria. Washington, D.C. American Society for Microbiology Press, 2000: 19-36.
Nature Cole ST 537 393 1998 10.1038/31159
Mol Microbiol Supply P 762 36 2000 10.1046/j.1365-2958.2000.01905.x
※ AI-Helper는 부적절한 답변을 할 수 있습니다.